Tolfenamic acid, 99+%
Tolfenamic acid, 99+%
Tolfenamic acid, 99+%
Thermo Scientific Chemicals

Tolfenamic acid, 99+%

NSAID that activates calcium-activated potassium channels | CAS: 13710-19-5 | C14H12ClNO2 | 261.705 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
5 g
10 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number J61256.06
also known as J61256-06
Price (EUR)
82,65
Online Exclusive
91,50
Save 8,85 (10%)
Each
Quantity:
5 g
Request bulk or custom format
Price (EUR)
82,65
Online Exclusive
91,50
Save 8,85 (10%)
Each
Chemical Identifiers
CAS13710-19-5
IUPAC Name2-[(4-chloro-3-methylphenyl)amino]benzoic acid
Molecular FormulaC14H12ClNO2
InChI KeyQDNMBJXNLJFNHT-UHFFFAOYSA-N
SMILESCC1=CC(NC2=CC=CC=C2C(O)=O)=CC=C1Cl
View more
SpecificationsSpecification SheetSpecification Sheet
Thin Layer Chromatography95.0% min.
Tolfenamic acid is a non-steroidal anti-inflammatory agent. It interferes with synthesis of β-amyloid precursor protein, and thus Aβ peptides, by promoting degradation of an essential transcription factor. It inhibits fMLP- and A23187-induced Ca2+ influx in human PMNL with an IC50 value of approximately 20 μM.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Soluble in water (slightly), acetone (∼10 mg/ml), DMSO (52 mg/ml at 25°C), methanol (∼10 mg/ml) and ethanol (50 mg/ml).

Notes
Stable under recommended storage conditions. Incompatible with oxidizing agents.
RUO – Research Use Only

General References:

  1. P.J.Pentikainen; P.J.Neuvonen; C.Backman. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. European Journal of Clinical Pharmacology. 1981, 19,(5), 359-365.
  2. H.Kankaanranta; E.Moilanen. Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes. Molecular Pharmacology. 1995, 47,(5), 1006-1013.